Glycosylation of recombinant proteins: problems and prospects.
about
N-glycosylation of recombinant human interferon-gamma produced in different animal expression systems.Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans.Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis - electrospray ionization - mass spectrometryEnhancement of recombinant human EPO production and glycosylation in serum-free suspension culture of CHO cells through expression and supplementation of 30Kc19.Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns.DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in micePotency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations.Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cellsPosttranslational processing of recombinant human interferon-gamma in animal expression systems.The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody.Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells.Isolation and analysis of a baculovirus vector that supports recombinant glycoprotein sialylation by SfSWT-1 cells cultured in serum-free medium.The effects of culture conditions on the glycosylation of secreted human placental alkaline phosphatase produced in Chinese hamster ovary cells.Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by Mammalian cell systems.Carbohydrate analysis throughout the development of a protein therapeutic.Glycosylation: impact, control and improvement during therapeutic protein production.Metabolic effects on recombinant interferon-gamma glycosylation in continuous culture of Chinese hamster ovary cells.Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics.What can mathematical modelling say about CHO metabolism and protein glycosylation?Effect of culture pH on recombinant antibody production by a new human cell line, F2N78, grown in suspension at 33.0 °C and 37.0 °C.A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins.Novel baculovirus expression vectors that provide sialylation of recombinant glycoproteins in lepidopteran insect cells.Improved bioprocess with CHO-hTSH cells on higher microcarrier concentration provides higher overall biomass and productivity for rhTSH.Non-core region modulates interleukin-11 signaling activity: generation of agonist and antagonist variants.An efficient platform for screening expression and crystallization of glycoproteins produced in human cells.Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human β1,4-galactosyltransferase and human CTLA4Ig.A two-dimensional protein map of Chinese hamster ovary cells.Getting the glycosylation right: implications for the biotechnology industry.Enhanced erythropoietin heterogeneity in a CHO culture is caused by proteolytic degradation and can be eliminated by a high glutamine levelEffects of ammonia on CHO cell growth, erythropoietin production, and glycosylation.Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli.N-glycan structures of human transferrin produced by Lymantria dispar (gypsy moth) cells using the LdMNPV expression system.Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains.Cloning of exoinulinase gene from Penicillium janthinellum strain B01 and its high-level expression in Pichia pastoris.Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle.Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in the milk of transgenic cloned cattle.N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma.Enhanced sialylation of EPO by overexpression of UDP-GlcNAc 2-epimerase/ManAc kinase containing a sialuria mutation in CHO cells.Characterization of adenosine receptor in its native environment: insights from molecular dynamics simulations of palmitoylated/glycosylated, membrane-integrated human A(2B) adenosine receptor.Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells.
P2860
Q30430759-9CF4D31A-EC04-45F2-ABC9-9C81446B25A3Q30873680-44802916-30E5-4B40-B3A3-B36F63C36D3AQ33807752-A135B52B-2355-494A-B955-A1B93F444490Q34309532-9C828CD2-0208-4C5F-9FC1-B7CC5E5956E0Q35137050-61AC38D3-1471-423A-8DF6-716EBEA58C48Q35845691-B63D4E05-219B-4F24-A4B2-3813003D115DQ35962591-507A57D2-9CC3-4E87-8BF5-1C5713AD56C1Q36254504-AEC9522C-ABAC-4407-83C6-71A50A2A986CQ36279636-6633741E-06E4-409B-9CE9-A20960BCFD08Q36670313-B38AD540-8865-4D54-8E36-4A7EBB31EE84Q36706838-8FAB7A95-7DC5-4E88-B043-3A17AEFBB195Q36730542-3999DB08-E880-44BF-A001-5E81C7331867Q37106821-65060FEB-555D-405D-A252-9E994F87ECF3Q37323542-60DA950F-8BBF-41B9-9F91-9B41C218F681Q37627225-16DE7FF3-46FA-42A2-98F1-535AE2FBD4B4Q38126913-E4F944AA-38C1-428F-AA24-130F012AA87BQ38326531-0C066E49-BA28-414E-A3E8-B3C97F91C705Q38591154-51B7789B-635B-4785-B59F-447B5C244F19Q38947322-0D5499FD-FB4D-479C-81C1-4EC1F443F8B1Q39172030-AA6C783B-5044-4889-86D5-106FF090C50FQ39462326-3F3308C1-6CB0-43C6-BC81-35E5C1644791Q39603349-05716227-E6D0-4E7B-9A4E-E81FBB0EC665Q39616628-E08E1577-CDDF-47E6-9887-8D0BEBB43F3CQ39622839-075DCC2C-3AB8-4D42-A303-7AFC32312C21Q39859955-50CC604A-28E2-413A-A095-219A168C233BQ40942617-FBD9DB73-CBD5-491F-BF2D-B18895E5F292Q40951866-2EF78ECC-B8DF-4BB6-83EE-CF6DA8F23228Q41176922-3B9CDE74-C6B1-44BE-B12F-7618C8712CA2Q41873068-2C83CB50-F0E5-409F-8D3D-C32548D285C0Q41921972-A827007B-437F-4B41-A1F5-B0E55B894D65Q42012779-835DAEEE-8070-4CA6-9197-598BA9CD7A24Q42048476-B1151305-2ABE-46B6-ACEC-EBA203C93855Q42050860-0A98CA40-86AB-4500-B588-D93C68077D73Q42615426-5537A2BB-E39A-4EBD-9304-68BA7C919C46Q43052323-E67F21F2-6907-4D98-8B5E-27158933A975Q43569961-2A3BD507-9B28-4C71-B098-791EB7F77215Q47138416-74AEF15F-C57B-4C3E-A7E3-A5A301D9DEEBQ50932279-7C56EDBE-4ED2-450F-A63A-14FF65337BE8Q53437158-1A1F3D58-D1FF-4E8F-A7F0-79455397A865Q55416256-83843C2D-15F9-4323-AE47-E4D79257CAAD
P2860
Glycosylation of recombinant proteins: problems and prospects.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Glycosylation of recombinant proteins: problems and prospects.
@en
type
label
Glycosylation of recombinant proteins: problems and prospects.
@en
prefLabel
Glycosylation of recombinant proteins: problems and prospects.
@en
P1476
Glycosylation of recombinant proteins: problems and prospects.
@en
P2093
P304
P356
10.1016/0141-0229(94)90149-X
P577
1994-05-01T00:00:00Z